LOW FREQUENCY GLATIRAMER ACETATE THERAPY
A method of alleviating a symptom of relapsing-remitting multiple sclerosis in a human patient suffering from relapsing-remitting multiple sclerosis or a patient who has experienced a first clinical episode and is determined to be at high risk of developing clinically definite multiple sclerosis com...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
13.06.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A method of alleviating a symptom of relapsing-remitting multiple sclerosis in a human patient suffering from relapsing-remitting multiple sclerosis or a patient who has experienced a first clinical episode and is determined to be at high risk of developing clinically definite multiple sclerosis comprising administering to the human patient three subcutaneous injections of a therapeutically effective dose of glatiramer acetate over a period of seven days with at least one day between every subcutaneous injection so as to thereby alleviate the symptom of the patient. |
---|---|
Bibliography: | Application Number: US201916272786 |